Synaptogenix Inc (SNPX)

[peeved]

I know you aren’t too keen on avxl

But with positive AD data in their subset of genetic patients(majority), do you think they can get to 200-400?

Do you think they will need separate phase 3? They should be next pharma up for AD results although results failed most companies thus far.

There is some data that most companies know half way through their trial that drug works…i wonder